FI3650048T3 - Väriaineita sisältävä suun kautta otettava kiinteä koostumus käytettäväksi endoskooppisessa diagnosoinnissa - Google Patents
Väriaineita sisältävä suun kautta otettava kiinteä koostumus käytettäväksi endoskooppisessa diagnosoinnissa Download PDFInfo
- Publication number
- FI3650048T3 FI3650048T3 FIEP19159230.2T FI19159230T FI3650048T3 FI 3650048 T3 FI3650048 T3 FI 3650048T3 FI 19159230 T FI19159230 T FI 19159230T FI 3650048 T3 FI3650048 T3 FI 3650048T3
- Authority
- FI
- Finland
- Prior art keywords
- dye
- administered
- use according
- solid composition
- during
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/006—Biological staining of tissues in vivo, e.g. methylene blue or toluidine blue O administered in the buccal area to detect epithelial cancer cells, dyes used for delineating tissues during surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/003—Thiazine dyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
- A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
- A61K49/0076—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form dispersion, suspension, e.g. particles in a liquid, colloid, emulsion
- A61K49/0084—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form dispersion, suspension, e.g. particles in a liquid, colloid, emulsion liposome, i.e. bilayered vesicular structure
- A61K49/0086—Polymersome, i.e. liposome with polymerisable or polymerized bilayered-forming substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
- A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
- A61K49/0089—Particulate, powder, adsorbate, bead, sphere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Optics & Photonics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biodiversity & Conservation Biology (AREA)
- Physics & Mathematics (AREA)
- Dispersion Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261715981P | 2012-10-19 | 2012-10-19 | |
| EP12189206.1A EP2722058A1 (en) | 2012-10-19 | 2012-10-19 | Solid oral composition containing dyes for use in endoscopic diagnosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FI3650048T3 true FI3650048T3 (fi) | 2025-05-26 |
Family
ID=47137560
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FIEP19159230.2T FI3650048T3 (fi) | 2012-10-19 | 2013-09-26 | Väriaineita sisältävä suun kautta otettava kiinteä koostumus käytettäväksi endoskooppisessa diagnosoinnissa |
Country Status (27)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112019010691A2 (pt) * | 2016-11-28 | 2019-10-01 | Cosmo Technologies Ltd | composição oral sólida contendo corantes |
| IT201900003113A1 (it) * | 2019-03-04 | 2020-09-04 | Azienda Ospedaliero Univ Policlinico S Orsola Malpighi Bologna | Bevanda coadiuvante |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2129273C1 (ru) * | 1997-11-26 | 1999-04-20 | Московский научно-исследовательский онкологический институт им.П.А.Герцена | Способ эндоскопической флюоресцентной диагностики злокачественных опухолей полых органов |
| EP1183014B1 (en) | 1999-06-14 | 2003-10-08 | Cosmo S.p.A. | Controlled release and taste masking oral pharmaceutical compositions |
| ITMI991316A1 (it) | 1999-06-14 | 2000-12-14 | Cip Ninety Two 92 S A | Composizioni farmaceutiche orali a rilascio modificato di mesalazina |
| US7230088B2 (en) * | 2001-07-03 | 2007-06-12 | Mallinckrodt, Inc. | Compounds for dual photodiagnosis and therapy |
| GB0224909D0 (en) * | 2002-10-25 | 2002-12-04 | Norgine Europe Bv | Colon cleansing compositions |
| RU2253350C2 (ru) * | 2003-06-30 | 2005-06-10 | Государственное учреждение здравоохранения Иркутский Областной Диагностический Центр | Способ эндоскопического исследования желудка |
| US20050244368A1 (en) * | 2004-04-29 | 2005-11-03 | Pashankar Dinesh S | Pre-endoscopic use of polyethylene glycol compositions |
| FR2894253B1 (fr) * | 2005-12-06 | 2009-11-13 | Pentax Corp | Composition d'histocolorant pour endoscope |
| IT1398643B1 (it) | 2010-03-04 | 2013-03-08 | Cosmo Technologies Ltd | Composizione solida per la somministrazione orale di coloranti, e utilizzo diagnostico della stessa |
-
2012
- 2012-10-19 EP EP12189206.1A patent/EP2722058A1/en not_active Withdrawn
-
2013
- 2013-09-26 FI FIEP19159230.2T patent/FI3650048T3/fi active
- 2013-09-26 EP EP19159230.2A patent/EP3650048B1/en active Active
- 2013-09-26 RS RSP20190499 patent/RS59152B1/sr unknown
- 2013-09-26 ES ES13774382T patent/ES2721916T3/es active Active
- 2013-09-26 RU RU2015118584A patent/RU2649783C2/ru active
- 2013-09-26 DK DK19159230.2T patent/DK3650048T3/da active
- 2013-09-26 MX MX2015004935A patent/MX361737B/es active IP Right Grant
- 2013-09-26 JP JP2015537181A patent/JP6267210B2/ja active Active
- 2013-09-26 CA CA2886201A patent/CA2886201C/en active Active
- 2013-09-26 LT LTEP13774382.9T patent/LT2908866T/lt unknown
- 2013-09-26 US US14/436,669 patent/US20150283268A1/en not_active Abandoned
- 2013-09-26 EP EP13774382.9A patent/EP2908866B1/en active Active
- 2013-09-26 NZ NZ706363A patent/NZ706363A/en unknown
- 2013-09-26 WO PCT/EP2013/070060 patent/WO2014060199A1/en active Application Filing
- 2013-09-26 ES ES19159230T patent/ES3030697T3/es active Active
- 2013-09-26 PT PT13774382T patent/PT2908866T/pt unknown
- 2013-09-26 IN IN2818DEN2015 patent/IN2015DN02818A/en unknown
- 2013-09-26 KR KR1020157010942A patent/KR102207507B1/ko active Active
- 2013-09-26 AU AU2013331964A patent/AU2013331964B2/en active Active
- 2013-09-26 CN CN201380053741.XA patent/CN104755107A/zh active Pending
- 2013-09-26 CN CN202110120798.3A patent/CN112891563A/zh active Pending
- 2013-09-26 BR BR112015008772A patent/BR112015008772A2/pt not_active Application Discontinuation
- 2013-09-26 HU HUE13774382A patent/HUE043112T2/hu unknown
- 2013-09-26 DK DK13774382.9T patent/DK2908866T3/da active
- 2013-09-26 HR HRP20190710TT patent/HRP20190710T1/hr unknown
- 2013-09-26 CN CN202311335014.4A patent/CN117462704A/zh active Pending
- 2013-09-26 TR TR2019/05800T patent/TR201905800T4/tr unknown
- 2013-09-26 PL PL13774382T patent/PL2908866T3/pl unknown
- 2013-10-10 AR ARP130103688A patent/AR091984A1/es not_active Application Discontinuation
- 2013-10-15 TW TW102137094A patent/TWI651102B/zh active
-
2015
- 2015-03-23 IL IL237907A patent/IL237907A/en active IP Right Grant
- 2015-04-09 ZA ZA2015/02370A patent/ZA201502370B/en unknown
-
2019
- 2019-06-12 US US16/439,284 patent/US20200129643A1/en not_active Abandoned
-
2022
- 2022-12-20 US US18/085,372 patent/US20230130628A1/en not_active Abandoned
-
2025
- 2025-01-17 US US19/028,220 patent/US20250186626A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2878575T3 (es) | Métodos para usar agonistas del FXR | |
| Parente et al. | 2-Litre polyethylene glycol-citrate-simethicone plus bisacodyl versus 4-litre polyethylene glycol as preparation for colonoscopy in chronic constipation | |
| CN102811747B (zh) | 用于口服施用染料的固体组合物及其诊断用途 | |
| JP2013521271A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| Parente et al. | Bowel preparation before colonoscopy in the era of mass screening for colo-rectal cancer: a practical approach | |
| JP2012529451A (ja) | ５−アミノレブリン酸を含む固体組成物 | |
| JP2017200948A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| US20250186626A1 (en) | Solid oral composition containing dyes for use in endoscopic diagnosis | |
| WO2019074214A9 (ko) | 황산염을 포함하는 대장 하제 조성물 | |
| CA2918004C (en) | A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation | |
| US11471425B2 (en) | Pharmaceutical composition containing broussochalcone a as active ingredient for treatment of inflammatory bowel disease | |
| JP2015534956A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| Jianfeng et al. | Enteral nutrition before bowel preparation improves the safety of colonoscopy in the elderly | |
| CN110234359A (zh) | 包含染料的固体口服组合物 | |
| Na et al. | Optimal laxatives for oral colonoscopy bowel preparation: from high-volume to novel low-volume solutions | |
| Mehta | Technologies & Clinical Studies for the Oral Delivery of Calcitonin | |
| Mallya et al. | Vitamin D abnormalities and supplementation in veterans receiving methadone maintenance: effects on pain, depression, and substance misuse | |
| Fort et al. | Analgesic doses of aspirin (ASA) cause significant upper gastrointestinal (UGI) damage: PA65020, a new combination of enteric-coated aspirin (EC-ASA) & immediate-release (IR) omeprazole significantly reduces the incidence of gastroduodenal ulcers (GU/DU) | |
| Jones et al. | Sodium oxybate improves function and quality of life in fibromyalgia–results from a phase 3, randomized, controlled trial | |
| Yeung et al. | Tu1367 Low Volume Polyethylene Glycol Versus Magnesium Citrate As Bowel Preparation for Colonoscopy: Comparing Adenoma Detection Rates |